HomepageEurope - Pharmaceutical Executive

ADVERTISEMENT

HomepageEurope

A New Approach to Managing Safety Information in Clinical Trials

September 22, 2009

Clinical trials are conducted to prove the efficacy and safety of drugs, so why, Michael Reynolds asks, is so much emphasis is still centred just on efficacy?

The power of medical animation

September 1, 2009

The mechanism of action (MOA) animation is becoming an increasingly popular way to convey important information about a drug, but pharma companies are being slow to realise its potential. Faiz Kermani reports.

Need a new non-executive director?

August 27, 2009

Nick Stephens, CEO of RSA, talks to Pharm Exec Europe about how his company's new register aims to widen the choice of — and choices open to — non-executive directors in the life sciences industry.

Patent litigation insurance: a win-win situation?

August 27, 2009

James Blick explains how patent litigation insurance has evolved into a valid — and potentially vital — option for pharmaceutical companies.

Sweden takes the reins

August 25, 2009

The presence of a high-flying Obama administration insider at the upcoming Swedish life sciences summit is just one indication of the seriousness with which the country taking its EU presidency.

Integrating EU and US regulation

August 18, 2009

Frost & Sullivan's recently released report — Drug Approval Process in Europe: An Outlook — advocates the integration of the EU and US drug approval processes.

Profile: Erin Gainer

August 18, 2009

Pharm Exec Europe talks to Dr Erin Gainer, newly-appointed CEO of HRA Pharma, about socially conscious projects, emergency contraception and her peripatetic past in public health and academia.

Key Account Management: always read the label

August 17, 2009

Dr Brian D. Smith traces the origins of key account management and how it applies in pharmaceutical markets.

Recession Proof Companies, Part 2: Norgine

August 17, 2009

With 22 consecutive years of European growth under its belt, Norgine is still going from strength to strength. CEO Peter Stein talks to Pharm Exec Europe about the secret of its success.

ADVERTISEMENT

Click here